Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02853643 · ClinicalTrials.gov registry record · Phase 1
Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers
A Phase 1 study, sponsored by Asana BioSciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT02853643 is a Phase 1 study that has completed, run by Asana BioSciences. The registered enrollment target is 22 participants.
The verdict
NCT02853643, a Phase 1 study, has completed, sponsored by Asana BioSciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and tolerability, and determine the blood levels (pharmacokinetics), in both a fed and fasted condition, of a single dose of ASN002. Healthy volunteers will be participants in the study.
Interventions
- DRUG ASN002
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-07 |
| Est. Completion | 2016-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02853643
The ClinicalTrials.gov registry entry for NCT02853643 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Asana BioSciences, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ASN002 is the first listed.
NCT02853643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02853643 about?
NCT02853643 is a clinical study titled "Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers". The purpose of this study is to evaluate the safety and tolerability, and determine the blood levels (pharmacokinetics), in both a fed and fasted condition, of a single dose of ASN002. Healthy volunteers will be participants in the study.
What is the current status of trial NCT02853643?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2016-07. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02853643?
The interventions under investigation include: ASN002 (DRUG).
Who is sponsoring clinical trial NCT02853643?
This trial is sponsored by Asana BioSciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.